Farallon Capital Management as of March 31, 2019
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 91 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Altaba | 16.4 | $2.0B | 28M | 74.12 | |
| Spdr S&p 500 Etf (SPY) | 9.7 | $1.2B | 4.3M | 282.48 | |
| Celgene Corporation | 6.4 | $795M | 8.4M | 94.34 | |
| Wabtec Corporation (WAB) | 3.7 | $460M | 6.2M | 73.72 | |
| Alphabet Inc Class C cs (GOOG) | 2.8 | $343M | 292k | 1173.31 | |
| Ihs Markit | 2.7 | $332M | 6.1M | 54.38 | |
| Booking Holdings (BKNG) | 2.6 | $323M | 185k | 1744.91 | |
| Iqvia Holdings (IQV) | 2.5 | $310M | 2.2M | 143.85 | |
| Facebook Inc cl a (META) | 2.5 | $305M | 1.8M | 166.69 | |
| Transunion (TRU) | 2.3 | $289M | 4.3M | 66.84 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 2.2 | $280M | 807k | 346.91 | |
| Visa (V) | 2.0 | $252M | 1.6M | 156.19 | |
| Fidelity National Information Services (FIS) | 1.9 | $240M | 2.1M | 113.10 | |
| Anthem (ELV) | 1.9 | $237M | 825k | 286.98 | |
| Playa Hotels & Resorts Nv (PLYA) | 1.9 | $234M | 31M | 7.63 | |
| Equifax (EFX) | 1.9 | $232M | 2.0M | 118.50 | |
| Citrix Systems | 1.6 | $198M | 2.0M | 99.66 | |
| Microsoft Corporation (MSFT) | 1.6 | $192M | 1.6M | 117.94 | |
| S&p Global (SPGI) | 1.5 | $192M | 912k | 210.55 | |
| Equinix (EQIX) | 1.5 | $189M | 417k | 453.16 | |
| General Dynamics Corporation (GD) | 1.5 | $183M | 1.1M | 169.28 | |
| Ascendis Pharma A S (ASND) | 1.4 | $177M | 1.5M | 117.70 | |
| Sherwin-Williams Company (SHW) | 1.3 | $166M | 384k | 430.71 | |
| Sea Ltd Adr Isin Us81141r1005 (SE) | 1.3 | $163M | 6.9M | 23.52 | |
| AstraZeneca (AZN) | 1.3 | $157M | 3.9M | 40.43 | |
| Cigna Corp (CI) | 1.2 | $152M | 945k | 160.82 | |
| Goldcorp | 1.2 | $148M | 13M | 11.44 | |
| Array BioPharma | 1.1 | $134M | 5.5M | 24.38 | |
| Arris | 0.9 | $118M | 3.7M | 31.61 | |
| Zogenix | 0.9 | $113M | 2.1M | 55.01 | |
| Acceleron Pharma | 0.9 | $111M | 2.4M | 46.57 | |
| Liberty Global Inc C | 0.8 | $104M | 4.3M | 24.21 | |
| Myokardia | 0.8 | $101M | 2.0M | 51.99 | |
| Fox Corporation (FOX) | 0.8 | $101M | 2.8M | 35.88 | |
| Liberty Global Inc Com Ser A | 0.8 | $98M | 3.9M | 24.92 | |
| Sage Therapeutics (SAGE) | 0.8 | $95M | 600k | 159.05 | |
| Enanta Pharmaceuticals (ENTA) | 0.7 | $90M | 940k | 95.52 | |
| Mirati Therapeutics | 0.7 | $88M | 1.2M | 73.30 | |
| Global Blood Therapeutics In | 0.6 | $79M | 1.5M | 52.93 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $78M | 650k | 119.19 | |
| Alibaba Group Holding (BABA) | 0.6 | $76M | 415k | 182.45 | |
| Exelixis (EXEL) | 0.6 | $71M | 3.0M | 23.80 | |
| Amarin Corporation (AMRN) | 0.5 | $68M | 3.3M | 20.76 | |
| Reata Pharmaceuticals Inc Cl A | 0.5 | $64M | 750k | 85.47 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.5 | $59M | 2.9M | 20.11 | |
| Iovance Biotherapeutics (IOVA) | 0.4 | $54M | 5.7M | 9.51 | |
| Novocure Ltd ord (NVCR) | 0.4 | $51M | 1.1M | 48.17 | |
| Fibrogen (FGEN) | 0.4 | $50M | 916k | 54.35 | |
| Walt Disney Company (DIS) | 0.4 | $49M | 440k | 111.03 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $47M | 500k | 93.45 | |
| Nxp Semiconductors N V (NXPI) | 0.4 | $47M | 535k | 88.39 | |
| Fate Therapeutics (FATE) | 0.3 | $44M | 2.5M | 17.57 | |
| Radius Health | 0.3 | $41M | 2.0M | 19.94 | |
| Sina Corporation | 0.3 | $39M | 650k | 59.24 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $35M | 1.9M | 18.35 | |
| CVS Caremark Corporation (CVS) | 0.3 | $34M | 625k | 53.93 | |
| Ready Cap Corp Com reit (RC) | 0.3 | $33M | 2.2M | 14.67 | |
| Codexis (CDXS) | 0.2 | $26M | 1.3M | 20.53 | |
| D Stemline Therapeutics | 0.2 | $26M | 2.0M | 12.85 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $26M | 700k | 37.64 | |
| Crispr Therapeutics (CRSP) | 0.2 | $26M | 725k | 35.72 | |
| Fox Corp (FOXA) | 0.2 | $26M | 709k | 36.71 | |
| Ptc Therapeutics Inc conv bd us | 0.2 | $25M | 24M | 1.02 | |
| Zymeworks | 0.2 | $26M | 1.6M | 16.18 | |
| Quotient | 0.2 | $23M | 2.5M | 9.01 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $23M | 1.8M | 12.57 | |
| Chemocentryx | 0.2 | $21M | 1.5M | 13.89 | |
| Progenics Pharmaceuticals | 0.2 | $20M | 4.2M | 4.64 | |
| Avrobio Ord (AVRO) | 0.2 | $20M | 900k | 22.05 | |
| Voyager Therapeutics (VYGR) | 0.1 | $19M | 1.0M | 19.14 | |
| Bemis Company | 0.1 | $18M | 316k | 55.48 | |
| Savara (SVRA) | 0.1 | $18M | 2.4M | 7.37 | |
| Zealand Pharma A/s- | 0.1 | $16M | 949k | 17.02 | |
| Clovis Oncology | 0.1 | $15M | 600k | 24.82 | |
| Clovis Oncology Inc note 1.250% 5/0 | 0.1 | $14M | 19M | 0.77 | |
| Cyclerion Therapeutics | 0.1 | $13M | 844k | 14.81 | |
| Nanostring Technologies (NSTGQ) | 0.1 | $9.6M | 400k | 23.93 | |
| Versum Matls | 0.1 | $11M | 210k | 50.31 | |
| Sprint | 0.1 | $9.0M | 1.6M | 5.65 | |
| Voya Financial (VOYA) | 0.1 | $9.2M | 185k | 49.96 | |
| Gossamer Bio (GOSS) | 0.1 | $8.2M | 378k | 21.67 | |
| Invitae (NVTAQ) | 0.1 | $7.0M | 300k | 23.42 | |
| Zafgen | 0.0 | $4.9M | 1.8M | 2.74 | |
| Pfenex | 0.0 | $3.7M | 600k | 6.18 | |
| Dynavax Technologies (DVAX) | 0.0 | $3.7M | 500k | 7.31 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $3.1M | 6.8M | 0.45 | |
| Assembly Biosciences | 0.0 | $2.0M | 100k | 19.69 | |
| Aptinyx | 0.0 | $2.7M | 670k | 4.05 | |
| Radius Health Inc note 3.000% 9/0 | 0.0 | $1.1M | 1.3M | 0.84 | |
| Translate Bio | 0.0 | $1.0M | 100k | 10.19 | |
| Gol Linhas Aereas Intlg S A spon adr p (GOLLQ) | 0.0 | $189k | 15k | 13.04 |
